JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Honer, M.
Right arrow Articles by Ametamey, S. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Honer, M.
Right arrow Articles by Ametamey, S. M.
Journal of Nuclear Medicine Vol. 45 No. 3 464-470
© 2004 by Society of Nuclear Medicine


Basic Science Investigations

Dynamic Imaging of Striatal D2 Receptors in Mice Using Quad-HIDAC PET

Michael Honer, PhD, Matthias Brühlmeier, MD, John Missimer, PhD, August P. Schubiger, PhD and Simon M. Ametamey, PhD

Center for Radiopharmaceutical Science, Paul Scherrer Institute, Villigen, Switzerland

The novel, dedicated small animal PET tomograph, quad-HIDAC, offers submillimeter resolution in instrumental characterization experiments. The aim of this study was to establish the tomograph’s utility in a biologic application and to demonstrate the feasibility of rapid dynamic neuroreceptor imaging in mice. Methods: We used the well-established, high-affinity dopamine D2 receptor PET ligand 18F-fallypride for imaging striatal D2 receptors in NMRI mice. Dynamic PET data were acquired using the quad-HIDAC tomograph and subject to 2 different kinetic modeling approaches. The cerebellum, a brain region devoid of D2 receptors, was chosen as a reference region for kinetic modeling. Results: The resolution of the quad-HIDAC camera allowed clear visualization of the left and right mouse striatum with high target-to-nontarget signal ratios. The sensitivity of the tomograph permitted the generation of time-activity curves with initial time frames of 120 s. PET experiments acquiring data for 150 min demonstrated that the binding potential of 18F-fallypride could be fitted robustly with both reference tissue models for scan durations of >=40 min. Voxel-wise modeling resulted in parametric maps of high quality. The values for the binding potential in the striatum reached approximately 14, consistent with striatum-to-cerebellum ratios extracted from regional time-activity curves. Comparison of in vivo PET imaging results with ex vivo postmortem tissue sampling analyses indicated discrepancies in signal intensity, possibly resulting from scatter and random background in the cerebellum region of interest and leading to an overestimation of cerebellar activity concentrations and degradation of striatum-to-cerebellum ratios in PET experiments. Intraperitoneal injection of the unlabeled D2 receptor antagonist haloperidol 30 min before intravenous injection of 18F-fallypride blocked tracer accumulation in the striatum by >95%. Conclusion: The quad-HIDAC camera represents a powerful tool for future dynamic neuroreceptor PET studies in mice and rats under numerous pharmacologic or pathophysiologic conditions.

Key Words: quad-HIDAC • small animal PET • 18F-fallypride • mouse striatum • tracer kinetic modeling




This article has been cited by other articles:


Home page
JNMHome page
A. Bettio, M. Honer, C. Muller, M. Bruhlmeier, U. Muller, R. Schibli, V. Groehn, A. P. Schubiger, and S. M. Ametamey
Synthesis and Preclinical Evaluation of a Folic Acid Derivative Labeled with 18F for PET Imaging of Folate Receptor-Positive Tumors
J. Nucl. Med., July 1, 2006; 47(7): 1153 - 1160.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
O. Riesterer, M. Honer, W. Jochum, C. Oehler, S. Ametamey, and M. Pruschy
Ionizing radiation antagonizes tumor hypoxia induced by antiangiogenic treatment.
Clin. Cancer Res., June 1, 2006; 12(11): 3518 - 3524.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
S. M. Ametamey, L. J. Kessler, M. Honer, M. T. Wyss, A. Buck, S. Hintermann, Y. P. Auberson, F. Gasparini, and P. A. Schubiger
Radiosynthesis and Preclinical Evaluation of 11C-ABP688 as a Probe for Imaging the Metabotropic Glutamate Receptor Subtype 5
J. Nucl. Med., April 1, 2006; 47(4): 698 - 705.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.